Why do people keep coming back? What makes a supervised drug consumption site feel like home

What is it about?

This rapid-ethnographic study examines why regular clients of a low-barrier harm reduction day centre in Vancouver's Downtown Eastside chose to attend this particular supervised consumption site consistently, often daily and exclusively, despite nine other such services operating within a four-square-kilometre area. Over six weeks, the researcher conducted around 200 hours of observation, five focus groups with 25 regular clients and 20 individual interviews. Four factors drove routine attendance: accessible location, integrated on-site services including food, laundry, showers and legal advice, a diverse harm reduction offer accommodating both injecting and smoking, and the site's atmosphere. Atmosphere was the most frequently cited differentiator and was characterised by three qualities: safety from physical, structural and police-related harm; familiarity with staff, peers and the environment; and inclusivity for all, including couples, pet owners and people who do not use drugs.

Featured Image

Why is it important?

Most supervised consumption site research measures population-level outcomes such as overdose deaths and emergency department visits, leaving the question of what keeps individual people engaged largely unanswered. This study addresses that gap directly, in a setting uniquely suited to it: a city where clients can actively choose between multiple competing services. The finding that atmosphere, specifically its safety, familiarity and inclusivity dimensions, is the primary differentiator has direct implications for service design and commissioning, particularly in countries like the UK and Ireland that are now opening or planning their first sites. The study also advances understanding of supervised consumption sites as inclusion health interventions, showing how a well-designed facility can provide routine, dignity, belonging and community for people who are among the most structurally marginalised, far beyond its core harm reduction function.

Perspectives